Novel tumor therapy strategies targeting endoplasmic reticulum-mitochondria signal pathways

• Published in: Ageing research reviews 2023-07, Vol.88, p.101951-101951, Article 101951
• Main Authors: Wu, Hongzheng, Chen, Wanxin, Chen, Zhenni, Li, Xianping, Wang, Min
• Format: Article
• Language: English
• Subjects: Calcium - metabolism; Cancer; Endoplasmic Reticulum - metabolism; Humans; MAM; Mitochondria - metabolism; Neoplasms - drug therapy; Neoplasms - metabolism; Signal Transduction; Therapeutic targets
• ISSN: 1568-1637; 1872-9649
• DOI: 10.1016/j.arr.2023.101951

Organelles form tight connections through membrane contact sites, thereby cooperating to regulate homeostasis and cell function. Among them, the contact between endoplasmic reticulum (ER), the main intracellular calcium storage organelles, and mitochondria has been recognized for decades, and its main roles in the ion and lipid transport, ROS signaling, membrane dynamic changes and cellular metabolism are basically determined. At present, many tumor chemotherapeutic drugs rely on ER-mitochondrial calcium signal to function, but the mechanism of targeting resident molecules at the mitochondria-associated endoplasmic reticulum membranes (MAM) to sensitize traditional chemotherapy and the new tumor therapeutic targets identified based on the signal pathways on the MAM have not been thoroughly discussed. In this review, we highlight the key roles of various signaling pathways at the ER-mitochondria contact site in tumorigenesis and focus on novel anticancer therapy strategies targeting potential targets at this contact site. •Multiple signal pathways at ER-mitochondria contacts are altered in cancer, providing attractive therapeutic targets.•Currently, novel drugs are being explored targeting other signal pathways besides the well-studied Ca2+ channels on MAM.•Therapeutic strategies based on MAM targeted drugs have great potential to develop precision medicine in cancer.